MARVAX | Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reactive protection
01-12-2023
-30-11-2027
01-12-2023
-30-11-2027
01-04-2024
-31-03-2027
01-12-2022
-30-11-2027
01-09-2019
-31-08-2025
01-09-2023
-31-08-2025
01-04-2017
-31-01-2022
01-11-2015
-31-12-2021
01-12-2022
-30-11-2024
01-01-2023
-31-12-2024
01-08-2022
-31-07-2025
01-11-2021
-31-10-2027
01-03-2019
-28-02-2022
01-03-2016
-28-02-2018
01-01-2025
-30-06-2026
01-09-2024
-28-02-2027
01-09-2024
-31-08-2026
01-04-2022
-30-09-2023
01-07-2018
-30-06-2024
01-02-2022
-31-01-2027
16-06-2015
-13-07-2018
01-01-2025
-30-06-2027
01-10-2018
-28-02-2021
16-01-2024
-15-01-2026
01-10-2023
-30-09-2025
01-09-2024
-28-02-2027
01-01-2023
-31-12-2027
01-09-2023
-31-08-2025
01-11-2022
-31-10-2025
01-05-2023
-30-04-2025
01-03-2016
-28-02-2022